Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 8
1.3 PEST Analysis 9
2 Report Outline 9
2.1 Report Scope 9
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Total Addressable Market 12
3.2 Segmented Addressable Market 12
3.3 Related Markets 13
3.3.1 Interventional Cardiology 13
3.3.2 Peripheral Vascular Stents 13
3.3.3 Atherectomy 14
4 Market Outlook 15
4.1 Market Definition - Infoholic Research 15
4.2 Causes for Coronary Heart Disease 15
4.3 Market Segmentation 15
4.4 Porter 5(Five) Forces 15
5 Market Characteristics 16
5.1 Evolution 16
5.2 Stents Platforms 17
5.3 Market Dynamics 18
5.3.1 Drivers 18
5.3.1.1 Increasing prevalence of cardiovascular diseases 18
5.3.1.2 Increasing aging population 18
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries 19
5.3.2 Opportunities 19
5.3.2.1 Market expansion opportunities in emerging nations 19
5.3.2.2 Increasing clinical trials 19
5.3.3 Restraints 19
5.3.3.1 Stringent regulations for approval 19
5.3.3.2 High cost of treatment associated with stent implants 20
5.3.3.3 Availability of alternative treatment procedure 20
5.4 DRO - Impact Analysis 20
5.5 Key Stakeholders 21
6 Coronary Stents Pipeline 22
6.1 Overview 22
7 Types: Market Size and Analysis 25
7.1 Overview 25
7.2 Bare Metal Stents (BMS) 25
7.3 Drug Eluting Stents 26
7.4 Bio-absorbable Stents 27
8 End-users: Market Size and Analysis 28
8.1 Overview 29
8.2 Hospitals 29
8.3 Ambulatory Surgical Centers (ASCs) 29
8.4 Cardiac Centers 30
9 Regions: Market Size and Analysis 30
9.1 Overview 30
9.2 North America 31
9.2.1 US 32
9.2.2 Canada 33
9.3 Europe 33
9.3.1 UK 34
9.3.2 Germany 34
9.3.3 France 35
9.4 Asia Pacific 35
9.4.1 Japan 36
9.4.2 China 36
9.4.3 India 36
9.5 Rest of the World 37
9.5.1 Africa 38
9.5.2 Brazil 38
10 Competitive Landscape 38
10.1 Overview 38
11 Vendors Profile 41
11.1 Abbott Laboratories (Abbott) 41
11.1.1 Overview 41
11.1.2 Business Unit 45
11.1.3 Geographic Presence 46
11.1.4 Business Focus 46
11.1.5 SWOT Analysis 47
11.1.6 Business Strategy 47
11.2 Boston Scientific Corp. (Boston) 48
11.2.1 Overview 48
11.2.2 Business Units 51
11.2.3 Geographic Presence 52
11.2.4 Business Focus 52
11.2.5 SWOT Analysis 53
11.2.6 Business Strategies 53
11.3 B. Braun Melsungen AG 54
11.3.1 Overview 54
11.3.2 Business Units 56
11.3.3 Geographic Presence 57
11.3.4 Business Focus 57
11.3.5 SWOT Analysis 58
11.3.6 Business Strategies 58
11.4 Medtronic Plc 59
11.4.1 Overview 59
11.4.2 Business Units 66
11.4.3 Geographic Presence 67
11.4.4 Business Focus 68
11.4.5 SWOT Analysis 69
11.4.6 Business Strategies 69
11.5 MicroPort Scientific Corporation 70
11.5.1 Overview 70
11.5.2 Business Units 73
11.5.3 Geographic Presence 74
11.5.4 Business Focus 75
11.5.5 SWOT Analysis 75
11.5.6 Business Strategies 76
12 Companies to Watch For 76
12.1 Terumo Corp. 77
12.1.1 Overview 77
12.2 Biosensors International Group 79
12.2.1 Overview 79
12.3 BIOTRONIK 80
12.3.1 Overview 80
12.4 Meril Life Science 81
12.4.1 Overview 81
12.5 STENTYS S.A. 82
12.5.1 Overview 82
12.5.2 Overview 82
Annexure 84
Abbreviations 84